当前位置:
X-MOL 学术
›
Pediatr. Diabetes
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
A high potency multi-strain probiotic improves glycemic control in children with new-onset type 1 diabetes mellitus: A randomized, double-blind, and placebo-controlled pilot study
Pediatric Diabetes ( IF 3.9 ) Pub Date : 2021-06-26 , DOI: 10.1111/pedi.13244 Sanjeev Kumar 1 , Rakesh Kumar 1 , Latika Rohilla 1 , Neenu Jacob 1 , Jaivinder Yadav 1 , Naresh Sachdeva 2
Pediatric Diabetes ( IF 3.9 ) Pub Date : 2021-06-26 , DOI: 10.1111/pedi.13244 Sanjeev Kumar 1 , Rakesh Kumar 1 , Latika Rohilla 1 , Neenu Jacob 1 , Jaivinder Yadav 1 , Naresh Sachdeva 2
Affiliation
Studies in animal models and humans with type 1 diabetes mellitus (T1DM) have shown that probiotic supplementation leads to decreased pro-inflammatory cytokines (responsible for damaging β-cells of the pancreas), improved gut barrier function, and induction of immune tolerance.
中文翻译:
一种高效多菌株益生菌可改善新发 1 型糖尿病儿童的血糖控制:一项随机、双盲和安慰剂对照试验研究
对患有 1 型糖尿病 (T1DM) 的动物模型和人类的研究表明,补充益生菌可以减少促炎细胞因子(负责破坏胰腺的 β 细胞)、改善肠道屏障功能和诱导免疫耐受。
更新日期:2021-06-26
中文翻译:
一种高效多菌株益生菌可改善新发 1 型糖尿病儿童的血糖控制:一项随机、双盲和安慰剂对照试验研究
对患有 1 型糖尿病 (T1DM) 的动物模型和人类的研究表明,补充益生菌可以减少促炎细胞因子(负责破坏胰腺的 β 细胞)、改善肠道屏障功能和诱导免疫耐受。